{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:13:40Z","timestamp":1793294020015,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jhepr.2023.100853","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T04:18:44Z","timestamp":1689740324000},"page":"100853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intestinal Pgc1\u03b1 ablation protects from liver steatosis and fibrosis"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-2689","authenticated-orcid":false,"given":"Elena","family":"Piccinin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-3290","authenticated-orcid":false,"given":"Maria","family":"Arconzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3966-3969","authenticated-orcid":false,"given":"Maria Laura","family":"Matrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Cariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bertrand-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-5321","authenticated-orcid":false,"given":"Gaetano","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-6074","authenticated-orcid":false,"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100853_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of MASLD and MASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100853_bib2","article-title":"Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?","volume":"2013","author":"Hafeez","year":"2013","journal-title":"J\u00a0Obes"},{"key":"10.1016\/j.jhepr.2023.100853_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of MASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100853_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep4.1858","article-title":"Pcsk9 deletion promotes murine nonalcoholic steatohepatitis and hepatic carcinogenesis: role of cholesterol","volume":"6","author":"Ioannou","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100853_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2023.100853_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut\u2013liver axis in MASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100853_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.32538","article-title":"Intestinal peroxisome proliferator-activated receptor \u0251-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis","volume":"77","author":"Yan","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100853_bib8","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/hep4.2053","article-title":"Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to MASLD and hepatocarcinoma","volume":"6","author":"Ducheix","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100853_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","article-title":"Metabolic aspects in MASLD, MASH and hepatocellular carcinoma: the role of PGC1 coactivators","volume":"16","author":"Piccinin","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100853_bib10","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.4161\/cc.10.17.16791","article-title":"Bax is necessary for PGC1\u0251 pro-apoptotic effect in colorectal cancer cells","volume":"10","author":"D'Errico","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jhepr.2023.100853_bib11","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1073\/pnas.1016354108","article-title":"Peroxisome proliferator-activated receptor-\u03b3 coactivator 1-\u0251 (PGC1\u0251) is a metabolic regulator of intestinal epithelial cell fate","volume":"108","author":"D'Errico","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2023.100853_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2011.09.013","article-title":"Modulation of longevity and tissue homeostasis by the Drosophila PGC-1 homolog","volume":"14","author":"Rera","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2023.100853_bib13","doi-asserted-by":"crossref","first-page":"10184","DOI":"10.1074\/jbc.M115.688812","article-title":"Peroxisome proliferator-activated receptor-\u03b3 coactivator 1-\u0251 (PGC1\u0251) protects against experimental murine colitis","volume":"291","author":"Cunningham","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100853_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026989","article-title":"Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor \u03b3 coactivator-1\u0251","volume":"6","author":"Pardo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100853_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cmet.2018.06.004","article-title":"Time-dependent molecular responses differ between gastric bypass and dieting but are conserved across species","volume":"28","author":"Ben-Zvi","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2023.100853_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110910","article-title":"ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPAR\u0251 activity","volume":"39","author":"Fougerat","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2023.100853_bib17","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1074\/jbc.M109927200","article-title":"Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors \u0251 and \u03b2","volume":"277","author":"Repa","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100853_bib18","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR\u0251 and LXR\u03b2","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhepr.2023.100853_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish MASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2023.100853_bib20","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.celrep.2018.11.100","article-title":"LXR suppresses inflammatory gene expression and neutrophil migration through cis-repression and cholesterol efflux","volume":"25","author":"Thomas","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2023.100853_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1388-1981(01)00190-1","article-title":"The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption","volume":"1580","author":"Altmann","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2023.100853_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","article-title":"Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis","volume":"12","author":"Lo Sasso","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2023.100853_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann\u2013Pick C1 like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2023.100853_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3188","article-title":"Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake","volume":"7","author":"Hu","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhepr.2023.100853_bib25","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1074\/jbc.M409110200","article-title":"Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia","volume":"280","author":"Davies","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100853_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2009.05.017","article-title":"Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease","volume":"51","author":"Nozaki","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100853_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2337\/dc09-1765","article-title":"Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet","volume":"33","author":"Chan","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhepr.2023.100853_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-511X-9-29","article-title":"NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease","volume":"9","author":"Enjoji","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhepr.2023.100853_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1872-034X.2010.00644.x","article-title":"Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study","volume":"40","author":"Yoneda","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2023.100853_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe\u00a0for the treatment of nonalcoholic steatohepatitis: assessment\u00a0by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100853_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s11095-007-9496-9","article-title":"HNF4\u0251 is a crucial modulator of the cholesterol-dependent regulation of NPC1L1","volume":"25","author":"Iwayanagi","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.jhepr.2023.100853_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11095-010-0294-4","article-title":"Human NPC1L1 expression is positively regulated by PPAR\u0251","volume":"28","author":"Iwayanagi","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.jhepr.2023.100853_bib33","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1074\/jbc.M512636200","article-title":"Partnership of PGC-1\u0251 and HNF4\u0251 in the regulation of lipoprotein metabolism","volume":"281","author":"Rhee","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100853_bib34","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor \u0251 in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2023.100853_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-physiol-012110-142233","article-title":"Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport","volume":"73","author":"Jia","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jhepr.2023.100853_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/hepr.12092","article-title":"Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse","volume":"44","author":"Wang","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2023.100853_bib37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR\u0251","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100853_bib38","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M204887200","article-title":"Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles","volume":"277","author":"Grefhorst","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100853_bib39","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.febslet.2010.03.030","article-title":"NPC1L1 and cholesterol transport","volume":"584","author":"Betters","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhepr.2023.100853_bib40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2017.03.001","article-title":"Selective chemical inhibition of PGC-1\u0251 gluconeogenic activity ameliorates type 2 diabetes","volume":"169","author":"Sharabi","year":"2017","journal-title":"Cell"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:34:24Z","timestamp":1762900464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2589555923001842"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100853","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal Pgc1\u03b1 ablation protects from liver steatosis and fibrosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100853"}}